Survive Ebola with vitamin C and selenium

Death through Nutritional Depletion
A comparison of immune parameters in survivors and non-survivors of infection has provided clues into the constituents of an effective immune response. Survival is dependent on the initial or innate immune response to infection. Survivors exhibited more significant IgM responses, clearance of viral antigen, and sustained T-cell cytokine responses, as indicated by high levels of T-cell-related mRNA in the peripheral blood. In contrast, antibodies specific for the virus were nearly undetectable in fatal cases.

Increases in the levels of inflammatory cytokines IFN-γ, IFN-α, interleukin-2 (IL-2), IL-10, and tumor necrosis factor alpha were associated with fatality from Ebola hemorrhagic fever (40). Whether the effects of cytokines are protective or damaging may depend not only on the cytokine profile but also may represent a delicate balance influenced by the route and titer of incoming virus as well as factors specific to the individual host immune response.[3] Bottom line is patients who die usually have not developed a significant immune response to the virus.

Ebola could impose an unprecedented selenium demand upon the host, potentially leading to severe lipid peroxidation and cell membrane destruction. This could also contribute to the characteristic hemorrhaging caused by intravascular blood clotting, due to the thrombotic effect of Se deficiency. Selenium, as we shall see in the Natural Allopathic Treatment section is one primary answer for cytokine storms.

Ebola is probably the best known of a class of viruses known as hemorrhagic fever viruses. The Cecil Textbook of Medicine notes that these diseases are characterized by capillary fragility, which translates to easy bleeding, that can frequently lead to severe shock and death. These diseases also tend to consume and/or destroy the platelets, which play an integral role in blood clotting. The clinical presentation of these viral diseases is similar to scurvy, which is also characterized by capillary fragility and a tendency to bleed easily. Characteristic skin lesions develop, which are actually multiple tiny areas of bleeding into the skin that surround the hair follicles. some cases even include bleeding into already healed scars.

In the classic form of scurvy, which evolves very slowly from the gradual depletion of vitamin C body stores, the immune system will be sufficiently compromised for infection to claim the patient’s life before the extensive hemorrhage that occurs after all vitamin C stores have been completely exhausted.
Ebola virus and the other viral hemorrhagic fevers are much more likely to cause hemorrhaging before any other fatal infection has a chance to become established. This is because the virus so rapidly and totally metabolizes and consumes all available vitamin C in the bodies of the victims that an advanced stage of scurvy is literally produced after only a few days of the disease.
The scurvy is so complete that the blood vessels generally cannot keep from hemorrhaging long enough to allow an infective complication to develop. In addition, the viral hemorrhagic fevers typically only take hold and reach epidemic proportions in those populations that would already be expected to have low body stores of vitamin C, such as are found in many of the severely malnourished Africans.
In such individuals, an infecting hemorrhagic virus will often wipe out any remaining vitamin C stores before the immune systems can get the upper hand and initiate recovery. When the vitamin C stores are rapidly depleted by large infecting doses of an aggressive virus, the immune system gets similarly depleted and compromised.

Conclusion
At this point we need to pray that worst case scenarios are not in our collective future. On the brighter side we are used to annual influenza scares, which seem little more than vaccine promotion campaigns. In the case ofEbola there is no vaccine and no treatment to promote but that does not mean we will not be surprised after a period of time that they do come out with a vaccine that they say will work but does not, just like a regular flu vaccine with toxic mercury included inside.

Some have speculated through the years that both the AIDS and Ebola are actually man made viruses, but at this point that is academic.

The Tap Blog is a collective of like-minded researchers and writers who’ve joined forces to distribute information and voice opinions avoided by the world’s media.
Print Friendly, PDF & Email
Facebooktwitterredditpinterestlinkedinmail

2 Responses to “Survive Ebola with vitamin C and selenium”

  1. Anonymous says:

    Nicotine renders the ebola virus inactive. This enables the bodies natural defense system the ability to destroy the virus.

    There is a remedy called ZMAp which is nicotine and has been tried and tested to work effectively at curing Ebola

    The Pharmaceutical companies aren’t interested in researching cures for ebola as not enough people die from it (contrary to media reports) so not cost effective for them, so it is left to the smaller medical research institutions to do of which they struggle to find enough funding, But, ZMap has been around a while and used successfully against ebola although it has not been approved yet. (I’m sure we can all guess why).

    Ebola is only transfered by bodily fluids

  2. Felipe says:

    Great article, everyone is watching this Ebola scare closely.

Leave a Reply

You must be logged in to post a comment.